Diabetes 1 & 2, IBD co-morbidity

No definition available.

Endpoint definition

FinnGen phenotype data

Filter registries None

Check pre-conditions None

diagram bullet diagram downward connector

Include endpoints

Check conditions None

Apply sex-specific rule None

diagram downward connector DM_IBD

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

Summary Statistics

Key figures

All Female Male
Number of individuals 44630 20394 24236
Unadjusted prevalence (%) 17.16 13.88 21.43
Mean age at first event (years) 54.91 53.76 55.87

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 3.19 [2.90, 3.51] <1e-100 6667
15 years 0.02 3.40 [3.14, 3.69] <1e-100 5507
5 years 0.00 4.36 [4.02, 4.74] <1e-100 2067
1 year 0.00 5.70 [4.91, 6.62] <1e-100 513

Correlations

Index endpoint: DM_IBD – Diabetes 1 & 2, IBD co-morbidity
GWS hits:

Survival analyses between endpoints

Plot

before Diabetes 1 & 2, IBD co-morbidity
after Diabetes 1 & 2, IBD co-morbidity

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Diabetes 1 & 2, IBD co-morbidity